Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record, with a small difference in title or year; 34 of the 34 references it cites were found in a registry or an index.

A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis

Open access

Abstract

BACKGROUND: The efficacy and safety of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis is still a matter of debate. METHODS: Using a two-by-two factorial design, we randomly assigned 400 patients with proximal deep-vein thrombosis who were at risk for pulmonary embolism to receive a vena caval filter (200 patients) or no filter (200 patients), and to receive low-molecular-weight heparin (enoxaparin, 195 patients) or unfractionated heparin (205 patients). The rates of recurrent venous thromboembolism, death, and major bleeding were analyzed at day 12 and at two years. RESULTS: At day 12, two patients assigned to receive filters (1.1 percent), as compared with nine patients assigned to receive no filters (4.8 percent), had had symptomatic or asymptomatic pulmonary embolism (odds ratio, 0.22; 95 percent confidence interval, 0.05 to 0.90). At two years, 37 patients assigned to the filter group (20.8 percent), as compared with 21 patients assigned to the no-filter group (11.6 percent), had had recurrent deep-vein thrombosis (odds ratio, 1.87; 95 percent confidence interval, 1.10 to 3.20). There were no significant differences in mortality or the other outcomes. At day 12, three patients assigned to low-molecular-weight heparin (1.6 percent), as compared with eight patients assigned to unfractionated heparin (4.2 percent), had had symptomatic or asymptomatic pulmonary embolism (odds ratio, 0.38; 95 percent confidence interval, 0.10 to 1.38). CONCLUSIONS: In high-risk patients with proximal deep-vein thrombosis, the initial beneficial effect of vena caval filters for the prevention of pulmonary embolism was counterbalanced by an excess of recurrent deep-vein thrombosis, without any difference in mortality. Our data also confirmed that low-molecular-weight heparin was as effective and safe as unfractionated heparin for the prevention of pulmonary embolism.

Overview

Integrity signals

Registry

Crossref · 10.1056/nejm199802123380701

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 34 references

Research works printed but not linked: 7

  1. Greenfield LJ, 1988, Surgery, 104, 706
  2. Greenfield LJ, 1996, Semin Vasc Surg, 9, 50
  3. Alexander JJ, 1986, Surg Gynecol Obstet, 163, 405
  4. Fink JA, 1991, Surg Gynecol Obstet, 172, 253
  5. Cohen JR, 1991, Surgery, 109, 12
  6. Golueke PJ, 1988, Surgery, 103, 111
  7. Byar DP, 1985, Cancer Treat Rep, 69, 1055

Cited by

See all 1,702

Metadata

Authors
Decousus, H., Leizorovicz, A., Parent, F., Page, Y., Tardy, B., Girard, P., Laporte, S., Faivre, R., Charbonnier, B., Barral, F.-G., Huet, Y., & Simonneau, G.
Affiliations
  • Hôpital Antoine-Béclère (FR)
  • Institute Mutualiste Montsouris (FR)
  • Centre Hospitalier Universitaire de Saint-Étienne (FR)
Venue
New England Journal of Medicine
Published
1998-02-12
Volume
338
Issue
7
Pages
409-416
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2312814626
Cited by
1,702
References
34
Citations by year
2026: 24 · 2025: 21 · 2024: 31 · 2023: 29 · 2022: 39 · 2021: 45 · 2020: 55 · 2019: 43 · 2018: 52 · 2017: 59 · 2016: 72 · 2015: 59 · 2014: 69 · 2013: 86 · 2012: 75
FWCI
46.03
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cardiovascular and Diving-Related Complications
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Keywords
vena caval filters, pulmonary embolism prevention, proximal deep vein thrombosis, low molecular weight heparin, enoxaparin, unfractionated heparin, recurrent deep vein thrombosis, venous thromboembolism, major bleeding, mortality
MeSH terms
Aged, Anticoagulants, Combined Modality Therapy, Female, Hemorrhage, Heparin, Humans, Male, Pulmonary Embolism, Recurrence, Thrombophlebitis, Survival Analysis, Vena Cava Filters, Treatment Outcome, Enoxaparin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis. https://app.cochat.ai/papers/10.1056/nejm199802123380701
The paper
Decousus, H., Leizorovicz, A., Parent, F., Page, Y., Tardy, B., Girard, P., Laporte, S., Faivre, R., Charbonnier, B., Barral, F.-G., Huet, Y., & Simonneau, G. (1998). A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis. New England Journal of Medicine. https://doi.org/10.1056/nejm199802123380701

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.